Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Aquestive Therapeutics Stock News

AQSTNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Aquestive Therapeutics (AQST) Forecast

News

Earnings Aquestive Therapeutics (AQST) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Aquestive Therapeutics Stock News | NASDAQ:AQST | Benzinga

Get the latest news on Aquestive Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Aquestive Therapeutics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, April 02, 2025

HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk - Apr 2, 2025, 7:18AM

Tuesday, April 01, 2025

Aquestive Therapeutics Concludes FDA Application For Allergy Drug With Encouraging Pediatric Trial Data
Vandana Singh - Apr 1, 2025, 10:54AM
Aquestive Therapeutics Announced Topline Resu...
Benzinga Newsdesk - Apr 1, 2025, 7:05AM

Monday, March 10, 2025

HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk - Mar 10, 2025, 7:43AM

Friday, March 07, 2025

Lake Street Maintains Buy on Aquestive Therap...
Benzinga Newsdesk - Mar 7, 2025, 4:11PM

Wednesday, March 05, 2025

Aquestive Therapeutics shares are trading low...
Benzinga Newsdesk - Mar 5, 2025, 4:31PM
Aquestive Therapeutics Sees FY2025 Total reve...
Benzinga Newsdesk - Mar 5, 2025, 4:08PM
Aquestive Therapeutics Q4 GAAP EPS $(0.19) Mi...
Benzinga Newsdesk - Mar 5, 2025, 4:07PM
Earnings Scheduled For March 5, 2025
Benzinga Insights - Mar 5, 2025, 3:32AM

Monday, January 13, 2025

Aquestive Therapeutics Outlines 2025 Goals, I...
Benzinga Newsdesk - Jan 13, 2025, 7:50AM

Friday, December 20, 2024

HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk - Dec 20, 2024, 7:42AM

Thursday, December 19, 2024

Aquestive Therapeutics shares are trading hig...
Benzinga Newsdesk - Dec 19, 2024, 10:58AM
Aquestive Therapeutics Secures FDA Orphan Dru...
Benzinga Newsdesk - Dec 19, 2024, 8:13AM
Aquestive Therapeutics Receives U.S. FDA Orph...
Benzinga Newsdesk - Dec 19, 2024, 8:09AM

Tuesday, December 17, 2024

Aquestive Therapeutics shares are trading hig...
Benzinga Newsdesk - Dec 17, 2024, 2:28PM
Developer Of EpiPen Alternative Aquestive Stock Undervalued Despite Strong Clinical Data, Analyst Sees Huge Upside
Vandana Singh - Dec 17, 2024, 1:56PM
Cantor Fitzgerald Initiates Coverage On Aques...
Benzinga Newsdesk - Dec 17, 2024, 8:53AM

Monday, December 02, 2024

Aquestive Therapeutics Announces DA Feedback ...
Benzinga Newsdesk - Dec 2, 2024, 8:59AM

Monday, November 11, 2024

HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk - Nov 11, 2024, 6:54AM

Wednesday, November 06, 2024

HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk - Nov 6, 2024, 7:20AM

Monday, November 04, 2024

Aquestive Therapeutics Q3 EPS $(0.13), Inline...
Benzinga Newsdesk - Nov 4, 2024, 5:02PM
Aquestive Therapeutics Affirms FY2024 Sales G...
Benzinga Newsdesk - Nov 4, 2024, 4:51PM

Friday, October 25, 2024

Leerink Partners Maintains Outperform on Aque...
Benzinga Newsdesk - Oct 25, 2024, 9:21AM
Aquestive Therapeutics To Present Analysis Of...
Benzinga Newsdesk - Oct 25, 2024, 8:03AM
HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk - Oct 25, 2024, 7:28AM

Thursday, October 24, 2024

Aquestive Therapeutics Announces Its Complete...
Benzinga Newsdesk - Oct 24, 2024, 8:05AM

Tuesday, October 08, 2024

JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk - Oct 8, 2024, 2:08PM

Monday, September 30, 2024

Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate
Vandana Singh - Sep 30, 2024, 2:25PM
Aquestive Therapeutics shares are trading hig...
Benzinga Newsdesk - Sep 30, 2024, 12:34PM
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk - Sep 30, 2024, 9:32AM
Leerink Partners Reiterates Outperform on Aqu...
Benzinga Newsdesk - Sep 30, 2024, 8:08AM
HC Wainwright & Co. Maintains Buy on Aquestiv...
Benzinga Newsdesk - Sep 30, 2024, 7:55AM

Friday, September 27, 2024

Aquestive Therapeutics Announces Completion O...
Benzinga Newsdesk - Sep 27, 2024, 8:39AM

Wednesday, August 14, 2024

Aquestive Therapeutics Reiterates Expected Ti...
Benzinga Newsdesk - Aug 14, 2024, 8:08AM
HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk - Aug 14, 2024, 6:54AM

Monday, August 12, 2024

JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk - Aug 12, 2024, 10:06AM

Wednesday, August 07, 2024

Aquestive Therapeutics shares are trading hig...
Benzinga Newsdesk - Aug 7, 2024, 8:49AM

Tuesday, August 06, 2024

Aquestive Therapeutics Sees FY24 Revenue $57M...
Benzinga Newsdesk - Aug 6, 2024, 5:59PM
Aquestive Therapeutics Q2 2024 GAAP EPS $(0.0...
Benzinga Newsdesk - Aug 6, 2024, 5:30PM

Friday, July 26, 2024

Aquestive Therapeutics shares are trading hig...
Benzinga Newsdesk - Jul 26, 2024, 2:14PM
HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk - Jul 26, 2024, 7:06AM

Thursday, July 25, 2024

Aquestive Therapeutics Releases Topline PK Da...
Benzinga Newsdesk - Jul 25, 2024, 8:05AM

Wednesday, June 26, 2024

JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk - Jun 26, 2024, 12:03PM

Tuesday, June 25, 2024

Oral Allergy Medication For Emergencies - Aquestive Therapeutics' Investigational Therapy Works Even With Exposure To Liquids Of Different Temperatures, Data Shows
Vandana Singh - Jun 25, 2024, 1:00PM
Aquestive Therapeutics Reports Topline Data F...
Benzinga Newsdesk - Jun 25, 2024, 8:05AM

Tuesday, June 18, 2024

Aquestive Therapeutics To Join Russell 3000 A...
Benzinga Newsdesk - Jun 18, 2024, 8:15AM

Wednesday, June 05, 2024

HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk - Jun 5, 2024, 7:17AM

Monday, June 03, 2024

Aquestive Therapeutics Appoints Cassie Jung A...
Benzinga Newsdesk - Jun 3, 2024, 8:28AM

Tuesday, May 28, 2024

Aquestive Therapeutics Announces Two Encore P...
Benzinga Newsdesk - May 28, 2024, 8:31AM

Friday, May 10, 2024

Leerink Partners Initiates Coverage On Aquest...
Benzinga Newsdesk - May 10, 2024, 3:00PM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved